interferon alfa-n3 (human leukocyte derived) (Alferon N Injection)
interferon alfa-n3 (human leukocyte derived) is an FDA-licensed reference biologic from AIM ImmunoTech Inc.. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
1989
Reference approved
Reference product
Alferon N Injection interferon alfa-n3 (human leukocyte derived)
AIM ImmunoTech Inc.
- Approved
- Oct 10, 1989
- Marketing
- Disc
- Center
- CDER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for interferon alfa-n3 (human leukocyte derived), in chronological order.
Reference approval
Approval date of the reference interferon alfa-n3 (human leukocyte derived) product.
37 yr 2 mo ago
Frequently asked questions
Are there biosimilars approved for interferon alfa-n3 (human leukocyte derived) (Alferon N Injection)?
No 351(k) biosimilars or interchangeable biosimilars referencing interferon alfa-n3 (human leukocyte derived) are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.